FindTrial
Sign In

Establishment and validation of clinical prediction model OF Intrahepatic cholestasis disease during pregnancy's adverse pregnancy outcomes

Establishment and validation of clinical prediction model OF Intrahepatic cholestasis disease during pregnancy's adverse pregnancy outcomes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000028821
Enrollment
Unknown
Registered
2020-01-04
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrahepatic cholestasis of pregnancy

Interventions

ICP:none
control group:none

Sponsors

IPMCH
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: This research will collect nearly 5 years in our hospital childbirth all maternal as the research object.According to a 2015 guide, has been on an empty stomach bile acid > 10 mu mol/L as ICP diagnostic criteria, divided into research group (ICP group) and control group (ICP), then the team will be divided into two subgroups of severe and mild.Due to the particularity of ICP this disease, this study adopts the retrospective study, in all subjects after giving birth to collect the clinical features, laboratory indices, auxiliary examination results, and birth outcomes, including all of the information.

Exclusion criteria

Exclusion criteria: This study included in all the ICP pregnant women, eliminate loss with the visitor

Design outcomes

Primary

MeasureTime frame
pregnancy outcome;—

Secondary

MeasureTime frame
information;Laboratory information;Imaging index;—

Countries

China

Contacts

Public ContactZhou Ye

The International Peace Maternity & Child Health Hospital of China welfare institute (IPMCH)

13916232488@163.com+86 021-64070434

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026